Interactive Q&A with Leading Physicians and Parents
Join us for a Q&A with a panel of the most published and most successful biomedical experts leading the field of Autism Spectrum Disorders coupled with parents who are actively utilizing biomedical interventions to help their children. Make the most of this rare opportunity and have your questions prepared. You will have the chance to learn from other parents' stories and concern, and have the chance for all these leading physicians weigh in on these issues.
Dan Rossignol, MD, FAAFP
Dr. Rossignol received his MD degree at the Medical College of Virginia and completed his residency in family medicine at the University of Virginia. After both his children were diagnosed with autism, he made it his mission to research and publish on autism. Since 2006, he has 23 publications and 3 book chapters concerning autism and related conditions. He is a Fellow of the American Academy of Family Physicians (FAAFP) and is president of the Medical Academy of Pediatric Special Needs (MAPS).
Richard E. Frye, MD, PhD
Richard Frye, MD, PhD is the Director of Autism Research and Associate Professor of Pediatrics at The University of Arkansas for Medical Sciences. He specializes in pediatric neurology disorders, including learning disabilities and dyslexia, autism, speech and language delay, attention deficit, tics and Tourette’s syndrome, sleep disorders, and epileptic encephalopathy. Dr. Frye is board certified in pediatrics and neurology and completed fellowships in behavioral neurology and psychology.
David Dornfeld, DO
David Dornfeld, DO, has been practicing Family Medicine for twenty-three years, with extensive experience covering the full spectrum of clinical Family Medicine. He has developed a special interest in working with children that have Autism Spectrum Disorders. His experience encompasses all spectrums of Family Medicine, Spinal manipulation, Chelation Therapy, IV Infusion Therapy and Hyperbaric Therapies.
Kyle Van Dyke, MD
Kyle Van Dyke recieved his MD from the University of Chicago and completed his redsidency in Family Medicine at the University of Virginia. He is board certified in Family Medicine. He became involved in autism after the diagnosis of his son 7 years ago. His interests include clinical interventions, mitochondria, and hyperbaric therapy.
James Neubrander, MD
Dr. Neubrander graduated from medical school in 1975, is board certified in Environmental Medicine, the medical director of two entities, scientific advisor to several organizations, and a well-known speaker nationally and internationally. Since the mid-90s he has treated 4000-5000 children on the autism spectrum. He is known as the Father of Methyl-B12 and the innovator of HBOT protocols used to treat children with autism and other disorders.
